Cite
HARVARD Citation
Lorente, D. et al. (n.d.). 2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC). European journal of cancer. pp. S504-. [Online].